Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06606028 · ClinicalTrials.gov registry record

Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma

A clinical trial of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC), sponsored by University of California, San Francisco.

Recruiting
Registry status
250
Enrollment target
1
Study location

NCT06606028 is a study of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC) that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 250 participants, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06606028, a study of Squamous Cell Carcinoma of Head and Neck and Cutaneous Squamous Cell Carcinoma (CSCC), is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
250 participants
Enrollment target
1
Study location

Study Summary

This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radiation or surgery.

Conditions Studied

Squamous Cell Carcinoma of Head and Neck Cutaneous Squamous Cell Carcinoma (CSCC) Squamous Cell Carcinoma Head and Neck Cancer (HNSCC) Squamous Cell Carcinoma of Skin

Interventions

  • PROCEDURE Blood Specimen Collection
  • OTHER Medical Record Review
  • PROCEDURE Tumor Tissue Collection

Study Locations (1)

California

  • University of California, San Francisco - San Francisco

Trial Details

FieldValue
Enrollment Target 250 participants
Start Date 2024-10-09
Est. Completion 2029-12-30

Sponsor

University of California, San Francisco

1,713 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06606028

The ClinicalTrials.gov registry entry for NCT06606028 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 250 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 164-participant average among 37 other Squamous Cell Carcinoma of Head and Neck trials with a reported enrollment target (52% higher). The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with Squamous Cell Carcinoma of Head and Neck appearing as the primary indexed condition, and to 3 interventions - of which Blood Specimen Collection is the first listed.

NCT06606028 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06606028 about?

NCT06606028 is a clinical study titled "Tumor-Informed ctDNA Testing for MRD Following Treatment of Squamous Cell Carcinoma". This is a single-center, non-interventional, observational study that evaluates the correlation of circulating tumor DNA (ctDNA) testing to cancer relapse for participants with squamous cell carcinomas (HNC) of the head and neck mucosa and skin after curative-intent primary radiation or surgery.

What is the current status of trial NCT06606028?

This trial is currently recruiting. The enrollment target is 250 participants. The study started on 2024-10-09. Estimated completion is 2029-12-30.

What conditions does trial NCT06606028 study?

This clinical trial studies the following conditions: Squamous Cell Carcinoma of Head and Neck, Cutaneous Squamous Cell Carcinoma (CSCC), Squamous Cell Carcinoma Head and Neck Cancer (HNSCC), Squamous Cell Carcinoma of Skin.

What interventions are being tested in trial NCT06606028?

The interventions under investigation include: Blood Specimen Collection (PROCEDURE), Medical Record Review (OTHER), Tumor Tissue Collection (PROCEDURE).

Who is sponsoring clinical trial NCT06606028?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06606028 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Squamous Cell Carcinoma of Head and Neck

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Squamous Cell Carcinoma of Head and Neck

All registered trials for this condition

Cutaneous Squamous Cell Carcinoma (CSCC)

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.